Phathom Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Corroborated by 2 sources from 2 publishers
globalhealth1d ago
TL;DR
Strategic Execution and Market Dynamics - Revenue more than doubled year-over-year, driven by the strategic pivot to prioritize high-frequency engagement with gastroenterologists (GIs) over primary care The following slide deck was published by Phathom Pharmaceuticals, Inc.